Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...

According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...

Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...

Quantum Strategy's David Roche says Europe's defense spending needs to increase by at least $200 billion as he discusses the ...

The French actor, 60, tells PEOPLE how he "manifested" his role in the 'Yellowstone' prequel series, which returns for season ...

Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...

Submission is supported by positive results from the Phase III REGENCY trial, which demonstrated that nearly half of patients ...

Genentech, a member of the Roche Group, announced new positive data from Stage 2 and Stage 3 of the National Institutes of Health-sponsored Phase III OUtMATCH study, which provide ...

Posay, the dermatologist-recommended leader in skincare, is thrilled to announce its partnership with the BNP Paribas Open as ...